Lupin Unveils 'Jeet' Patient Support Program to Enhance Cardiovascular Disease Awareness among Patients

Jeet provides a comprehensive strategy to bolster the doctor-patient connection. Its focus extends to heightening awareness of cardiovascular ailments and their accompanying co-morbid conditions.

Lupin Limited has unveiled 'Jeet,' a patient support program promoting heart health. This initiative, coinciding with India's 77th Independence Day, signifies liberation from disease-induced stress and embarks on a journey towards enhanced well-being.

Jeet emerges as a dependable ally in cardiovascular care, offering services encompassing cost-effective medical solutions, disease counseling, medication reminders, and lifestyle guidance.

Accessible through the Play or App Store, as well as its official website, Jeet provides a comprehensive strategy to bolster the doctor-patient connection. Its focus extends to heightening awareness of cardiovascular ailments and their accompanying co-morbid conditions.

The program's framework is designed to motivate healthier lifestyle preferences and cultivate an environment conducive to a heart-healthy existence.

The program introduces a unique incentive system by bestowing '˜heartbeats' to measure adherence to medication schedules and lifestyle modifications.

It also offers users the convenience of uploading prescriptions and orchestrating tasks to elicit timely notifications. This aids in the prompt consumption of medications and mitigates the likelihood of overlooked doses.

Commenting on the same, Rajeev Sibal, president of India Region Formulations at Lupin, said, "Technology has the potential to improve outcomes by increasing patients' awareness of their condition and possible lifestyle interventions."

He further articulated Jeet's central objective: to furnish patients with an all-encompassing support framework that elevates medication adherence, lifestyle integration, and holistic well-being.

The primary objective of Jeet is to enable individuals to adopt healthier and more fulfilling lifestyles. This initiative highlights Lupin's contribution to patient-focussed efforts and advancing healthcare standards across India.

Lupin was founded in 1968 by Desh Bandhu Gupta, a multinational pharmaceutical enterprise headquartered in Mumbai, India.

The company's endeavors encompass the development and distribution of a diverse spectrum of branded and generic formulations, biotechnological products, and APIs across more than 100 markets, spanning the US, India, South Africa, as well as the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

There was a continued contribution by Lupin to Indian healthcare. On August 23, the company launched LYFE, a digital therapeutic solution for holistic heart care. Digital therapeutic solution LYFE caters to individuals seeking comprehensive heart care. The platform delivers personalised treatment plans by leveraging advanced algorithms and artificial intelligence.